These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2979786)

  • 1. Biological activities and antitumor mechanism of an immunopotentiating organogermanium compound, Ge-132 (review).
    Brutkiewicz RR; Suzuki F
    In Vivo; 1987; 1(4):189-203. PubMed ID: 2979786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor mechanisms of carboxyethyl-germanium sesquioxide (Ge-132) in mice bearing Ehrlich ascites tumors].
    Suzuki F
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):127-34. PubMed ID: 3800401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ability of sera from mice treated with Ge-132, an organo-germanium compound, to inhibit experimental murine ascites tumors].
    Suzuki F
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2314-21. PubMed ID: 3935051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
    Suzuki F; Brutkiewicz RR; Pollard RB
    Anticancer Res; 1986; 6(2):177-82. PubMed ID: 3085573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes].
    Suzuki F
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1445-52. PubMed ID: 3874600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
    Suzuki F; Brutkiewicz RR; Pollard RB
    Anticancer Res; 1985; 5(5):479-83. PubMed ID: 3877491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours.
    Suzuki F; Brutkiewicz RR; Pollard RB
    Br J Cancer; 1985 Nov; 52(5):757-63. PubMed ID: 3933536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppression of tumor growth by peritoneal macrophages isolated from mice treated with carboxyethylgermanium sesquioxide (Ge-132)].
    Suzuki F
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2122-8. PubMed ID: 4062310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57BL/6 (B6) mice.
    Kumano N; Ishikawa T; Koinumaru S; Kikumoto T; Suzuki S; Nakai Y; Konno K
    Tohoku J Exp Med; 1985 May; 146(1):97-104. PubMed ID: 4024087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli.
    Suzuki F; Brutkiewicz RR; Pollard RB
    J Natl Cancer Inst; 1986 Aug; 77(2):441-7. PubMed ID: 3090339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of suppressed interferon gamma production in thermally injured mice by administration of a novel organogermanium compound, Ge-132.
    Suzuki F; Pollard RB
    J Interferon Res; 1984; 4(2):223-33. PubMed ID: 6431019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
    Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of NK-421 (Bestatin) and Ge-132 on the cytotoxicity of spleen cells obtained from the tumor-bearing mice].
    Ono M; Oka T; Yoshihara H; Tanaka N; Miwa H; Mannami T; Konaga E; Orita K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1771-7. PubMed ID: 7184374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101.
    Sredni B; Tichler T; Shani A; Catane R; Kaufman B; Strassmann G; Albeck M; Kalechman Y
    J Natl Cancer Inst; 1996 Sep; 88(18):1276-84. PubMed ID: 8797767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound.
    Aso H; Suzuki F; Yamaguchi T; Hayashi Y; Ebina T; Ishida N
    Microbiol Immunol; 1985; 29(1):65-74. PubMed ID: 2581116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound].
    Aso H; Suzuki F; Yamaguchi T; Hayashi Y; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1976-80. PubMed ID: 6191691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of combination immunochemotherapy with an organogermanium compound, Ge-132, and antitumor agents on C57BL/6 mice bearing Lewis lung carcinoma (3LL)].
    Kobayashi H; Komuro T; Furue H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2588-93. PubMed ID: 2427032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells.
    Ikemoto K; Kobayashi M; Fukumoto T; Morimatsu M; Pollard RB; Suzuki F
    Experientia; 1996 Feb; 52(2):159-66. PubMed ID: 8608818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
    J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro.
    Buhtoiarov IN; Lum H; Berke G; Paulnock DM; Sondel PM; Rakhmilevich AL
    J Immunol; 2005 May; 174(10):6013-22. PubMed ID: 15879094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.